niacinamide has been researched along with Lymphoproliferative Disorders in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Lymphoproliferative Disorders: Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guidetti, A | 1 |
| Carlo-Stella, C | 1 |
| Locatelli, SL | 1 |
| Malorni, W | 1 |
| Mortarini, R | 1 |
| Viviani, S | 1 |
| Russo, D | 1 |
| Marchianò, A | 1 |
| Sorasio, R | 1 |
| Dodero, A | 1 |
| Farina, L | 1 |
| Giordano, L | 1 |
| Di Nicola, M | 1 |
| Anichini, A | 1 |
| Corradini, P | 1 |
| Gianni, AM | 1 |
1 trial available for niacinamide and Lymphoproliferative Disorders
| Article | Year |
|---|---|
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Extracellular S | 2014 |